Rapid Micro Biosystems to Participate at the PDA Pharmaceutical Microbiology Conference 2026
Key Highlights
- ➤Rapid Micro Biosystems (RPID) will sponsor PDA Pharmaceutical Microbiology Conference 2026.
- ➤Conference runs October 26-28 in Washington, D.C., featuring RPID at Booth 101.
- ➤Growth Direct platform will anchor presentations from multiple leading top 20 pharmaceutical companies.
- ➤Boehringer Ingelheim presentation will evaluate RMBNucleus Mold Alarm and AI mold-contamination detection.
- ➤Growth Direct automates microbial quality-control testing across environmental monitoring, water, bioburden, and sterility applications.
Expert Statements
Robert Spignesi, President and Chief Executive Officer of Rapid Micro Biosystems
“We are encouraged by the rapidly growing industry focus on modernizing microbial quality control through greater automation, digitalization and data integrity”
Robert Spignesi, President and Chief Executive Officer of Rapid Micro Biosystems
“Seeing the Growth Direct® platform as the focal point of multiple conference presentations from leading top 20 pharmaceutical companies reflects the increasingly important role that full automation and data-driven quality operations are playing with respect to automating mission critical workflows, regulatory compliance and standardization.”
Robert Spignesi, President and Chief Executive Officer of Rapid Micro Biosystems
“We look forward to engaging with customers and industry experts as they share practical experiences leveraging automation to advance quality and operational efficiency across their organizations.”
LEXINGTON, Mass., Oct. 20, 2026 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission-critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, today announced its participation as a sponsor of the PDA Pharmaceutical Microbiology Conference 2026, taking place in Washington, D.C. from October 26-28.
The conference brings together microbiology professionals, quality leaders and regulatory experts from across the pharmaceutical industry to share practical experience, emerging technologies and evolving regulatory perspectives shaping the future of pharmaceutical microbiology.
Get started
Create a free account to read the full story.